D
HUTCHMED (China) Limited HCM
$14.16 -$1.09-7.15%
Recommendation
Sell
Prev Close
$15.25
Volume
50,710
Avg Vol (90D)
83,248
Market Cap
$2.62B
Dividend & Yield
--
52-Week Range
$12.84 - $21.92
P/E (TTM)
381.25
EPS (TTM)
$0.04
My Lists My Alerts
Rating
Reward
D
Weak
Risk
D-
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Weak
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
HUTCHMED (China) (HCM, $15.25) Moving Average Convergence Divergence (MACD) Histogram turned negative on April 3, 2025
4/4/2025 - Tickeron - Stocks
HUTCHMED (NASDAQ:HCM) Trading Up 7.5% - Here's Why
4/3/2025 - MarketBeat
HUTCHMED (China) (HCM, $15.9) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 2, 2025
4/3/2025 - Tickeron - Stocks
HUTCHMED (China) Limited (NASDAQ:HCM) Shares Sold by Schroder Investment Management Group
4/3/2025 - MarketBeat
HUTCHMED (China) (HCM, $15.25) Stochastic Oscillator left the oversold zone on March 28, 2025
3/29/2025 - Tickeron - Stocks
HUTCHMED (NASDAQ:HCM) Shares Gap Up - Here's Why
3/28/2025 - MarketBeat
HUTCHMED (China) Ltd (HCM) Trading 7.45% Higher on Mar 27
3/27/2025 - GuruFocus
HUTCHMED (NASDAQ:HCM) Shares Gap Down - Time to Sell?
3/26/2025 - MarketBeat
HUTCHMED (China) (HCM, $14.62) price exceeded its 50-day Moving Average on March 25, 2025
3/26/2025 - Tickeron - Stocks
HUTCHMED (China) (HCM, $14.62) Stochastic Oscillator left the oversold zone on March 25, 2025
3/26/2025 - Tickeron - Stocks
IBBQ's Holdings Imply 42% Gain Potential
3/26/2025 - ETF Channel
HUTCHMED (NASDAQ:HCM) Rating Increased to Buy at StockNews.com
3/23/2025 - MarketBeat
HUTCHMED (NASDAQ:HCM) Stock Price Down 5.7% - Time to Sell?
3/22/2025 - MarketBeat
HUTCHMED (China) Ltd (HCM) Shares Gap Down to $14.98 on Mar 22
3/22/2025 - GuruFocus
HUTCHMED Announces Board Changes with Retirement of Key Directors
3/21/2025 - GuruFocus
HUTCHMED Announces Board Changes with Retirement of Key Directors
3/21/2025 - GuruFocus
HUTCHMED (China) Ltd (HCM) Announces Promising Results from Lung Cancer Trials
3/21/2025 - GuruFocus
HUTCHMED (China) Ltd (HCM) Reports Strong Oncology Revenue Growth and Strategic Developments
3/21/2025 - GuruFocus
HUTCHMED Announces NMPA Conditional Approval for TAZVERIK (tazemetostat) for the Treatment of Relapsed or Refractory Follicular Lymphoma
3/21/2025 - Globe Newswire
HUTCHMED (NASDAQ:HCM) Shares Gap Up - What's Next?
3/20/2025 - MarketBeat
HUTCHMED Announces Board Changes Following Director Retirements
3/20/2025 - TipRanks Financial Blog
Intended Retirement of Independent Non-executive Directors and changes of composition of board committees
3/20/2025 - Globe Newswire
HUTCHMED (China) (HCM, $16.18) Stochastic Oscillator left the oversold zone on March 19, 2025
3/20/2025 - Tickeron - Stocks
HUTCHMED (China) Ltd (HCM) (Q4 2024) Earnings Call Highlights: Achieving Profitability and ...
3/20/2025 - GuruFocus
Full Year 2024 HUTCHMED (China) Ltd Earnings Call Transcript
3/20/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$630.20M
EBITDA (TTM)
-$31.36M
EBIT (TTM)
-$43.71M
Net Income (TTM)
$37.73M
Balance Sheet
Total Assets (Q)
$1.27B
Total Debt (Q)
$89.82M
Total Liabilities (Q)
$502.34M
Book Value Per Share (Q)
$0.8889
Cash Flow
Cash from Operations (TTM)
$497.00K
Cash from Investing (TTM)
-$96.06M
Cash from Financing (TTM)
-$30.67M
Net Change in Cash (TTM)
-$129.63M
Filings
Filing Date
Wednesday, March 19, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
End of July (est)
Price History
Loading...
Beta
0.76
7-Day Total Return
-0.42%
30-Day Total Return
-12.10%
60-Day Total Return
-6.66%
90-Day Total Return
-19.91%
Year to Date Total Return
-6.10%
1-Year Total Return
-16.06%
2-Year Total Return
6.95%
3-Year Total Return
-31.82%
5-Year Total Return
-22.54%
52-week Low
Feb 12, 2025 - $12.84
52-week High
May 10, 2024 - $21.92
Valuation
Market Cap
$2.62B - Mid Cap
Enterprise Value
$1.85B
Price/Sales (TTM)
21.13
Price/Book (Q)
17.16
Dividends and Shares
Shares Outstanding
873.12M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.hutch-med.com
Phone Number
852 2121 8200
Address
Cheung Kong Center
48th floor - 2 Queen's Road Central
Hong Kong,
Country
Hong Kong
Year Founded
2000
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong... more
NASDAQ 04/04/2025 1:31PM Eastern Quotes delayed
Weiss Ratings